Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/201170
Title: | Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: from animal to clinical studies |
Author: | Ten-Blanco, Marc Flores de los Heros, África Cristino, Luigia Pereda Pérez, Inmaculada Berrendero, Fernando |
Keywords: | Malalties neurodegeneratives Neuropèptids Animals Proteïnes G Neurodegenerative Diseases Neuropeptides Animals G Proteins |
Issue Date: | 2-Apr-2023 |
Publisher: | Elsevier |
Abstract: | Orexins (also known as hypocretins) are neuropeptides located exclusively in hypothalamic neurons that have extensive projections throughout the central nervous system and bind two different G protein-coupled receptors (OX1R and OX2R). Since its discovery in 1998, the orexin system has gained the interest of the scientific community as a potential therapeutic target for the treatment of different pathological conditions. Considering previous basic science research, a dual orexin receptor antagonist, suvorexant, was the first orexin agent to be approved by the US Food and Drug Administration to treat insomnia. In this review, we discuss and update the main preclinical and human studies involving the orexin system with several psychiatric and neurodegenerative diseases. This system constitutes a nice example of how basic scientific research driven by curiosity can be the best route to the generation of new and powerful pharmacological treatments. |
Note: | Reproducció del document publicat a: https://doi.org/10.1016/j.yfrne.2023.101066 |
It is part of: | Frontiers in Neuroendocrinology, 2023, vol. 69, num. 101066 |
URI: | http://hdl.handle.net/2445/201170 |
Related resource: | https://doi.org/10.1016/j.yfrne.2023.101066 |
ISSN: | 0091-3022 |
Appears in Collections: | Articles publicats en revistes (Patologia i Terapèutica Experimental) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
733413.pdf | 11.17 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License